Cargando…

Circulating Mitochondrial DNA is Linked to Progression and Prognosis of Epithelial Ovarian Cancer

As peripheral blood contains fluctuated levels of circulating cell-free mitochondrial DNA (ccf mtDNA), we aimed to evaluate ccf mtDNA as a biomarker for diagnosis and prognosis of epithelial ovarian cancer (EOC). In the present study, we recruited 165 EOC patients and 60 healthy women. Quantitative...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Xiaodan, Schwarzenbach, Heidi, Yang, Yifeng, Müller, Volkmar, Li, Nan, Tian, Dongmei, Shen, Yan, Gong, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2019
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609736/ https://www.ncbi.nlm.nih.gov/pubmed/31271962 http://dx.doi.org/10.1016/j.tranon.2019.05.015

Ejemplares similares

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

Exosomal microRNAs as tumor markers in epithelial ovarian cancer
por: Pan, Chi, et al.
Publicado: (2018)

Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Apoptosis-related deregulation of proteolytic activities and high serum levels of circulating nucleosomes and DNA in blood correlate with breast cancer progression
por: Roth, Carina, et al.
Publicado: (2011)

Circulating microRNAs: promising breast cancer biomarkers - authors' response
por: Roth, Carina, et al.
Publicado: (2011)

Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer
por: Roth, Carina, et al.
Publicado: (2010)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Circulating nucleic acids as biomarkers in breast cancer
por: Schwarzenbach, Heidi
Publicado: (2013)

Circulating Mitochondrial DNA as Biomarker Linking Environmental Chemical Exposure to Early Preclinical Lesions Elevation of mtDNA in Human Serum after Exposure to Carcinogenic Halo-Alkane-Based Pesticides
por: Budnik, Lygia T., et al.
Publicado: (2013)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Interplay of lncRNA H19/miR‐675 and lncRNA NEAT1/miR‐204 in breast cancer
por: Müller, Volkmar, et al.
Publicado: (2019)

Resistance to cis- and carboplatin initiated by epigenetic changes in ovarian cancer patients
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2007)

LOH at 6q and 10q in fractionated circulating DNA of ovarian cancer patients is predictive for tumor cell spread and overall survival
por: Kuhlmann, Jan Dominik, et al.
Publicado: (2012)

Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2018)

Author Correction: Different signatures of miR-16, miR-30b and miR-93 in exosomes from breast cancer and DCIS patients
por: Ni, Qingtao, et al.
Publicado: (2019)

The current role of circulating biomarkers in non-muscle invasive bladder cancer
por: Rink, Michael, et al.
Publicado: (2019)

Clinical significance for combined coagulation indexes in epithelial ovarian cancer prognosis
por: Yang, Jiani, et al.
Publicado: (2021)

Identification of Potential Biomarkers in Association With Progression and Prognosis in Epithelial Ovarian Cancer by Integrated Bioinformatics Analysis
por: Liu, Jinhui, et al.
Publicado: (2019)

Circulating Vitamin D and Risk of Epithelial Ovarian Cancer
por: Arslan, Alan A., et al.
Publicado: (2009)

The HSP70 gene predicts prognosis and response to chemotherapy in epithelial ovarian cancer
por: Li, Xiao-Fei, et al.
Publicado: (2021)

Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition
por: Yang, Jiani, et al.
Publicado: (2021)

E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer
por: Zhang, Xiaodan, et al.
Publicado: (2017)

Expression of Circulating MicroRNA-141 in Epithelial Ovarian Cancer
por: Fitriawan, Akbar Satria, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Characterization of circulating molecules and activities in plasma of patients after allogeneic and autologous intraoral bone grafting procedures: a prospective randomized controlled clinical trial in humans
por: Solakoglu, Önder, et al.
Publicado: (2022)

Predictive diagnostics in colorectal cancer: impact of genetic polymorphisms on individual outcomes and treatment with fluoropyrimidine-based chemotherapy
por: Schwarzenbach, Heidi
Publicado: (2010)

Biological and Clinical Relevance of H19 in Colorectal Cancer Patients
por: Schwarzenbach, Heidi
Publicado: (2016)

LncRNA SNHG20 predicts a poor prognosis and promotes cell progression in epithelial ovarian cancer
por: Wang, Dandan, et al.
Publicado: (2019)

Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer
por: Jeon, Hyeji, et al.
Publicado: (2022)

Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
por: Tsofack, Serges P, et al.
Publicado: (2013)

Promoter- and cell-specific epigenetic regulation of CD44, Cyclin D2, GLIPR1 and PTEN by Methyl-CpG binding proteins and histone modifications
por: Müller, Imke, et al.
Publicado: (2010)

Overexpression of Runt-Related Transcription Factor-2 Is Associated with Advanced Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer
por: Li, Weiping, et al.
Publicado: (2012)

Co-expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis
por: Liu, Juanjuan, et al.
Publicado: (2019)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Adipocytes: active facilitators in epithelial ovarian cancer progression?
por: Dai, Lan, et al.
Publicado: (2020)

Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives
por: Müller, Volkmar, et al.
Publicado: (2004)

Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer
por: Tamez, S, et al.
Publicado: (2009)

Expression of resistance gene and prognosis of chemotherapy in primary epithelial ovarian cancer
por: Yang, Fengmei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qo53g5ii0ne8cu4u142h03tgnl